ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 189 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $4,309,364 | +26.9% | 73,501 | -2.9% | 1.21% | +21.9% |
Q1 2019 | $3,394,572 | +7.1% | 75,721 | -6.9% | 0.99% | -42.3% |
Q4 2018 | $3,169,400 | -42.3% | 81,371 | -31.8% | 1.72% | -28.8% |
Q3 2018 | $5,493,453 | -6.1% | 119,371 | -11.0% | 2.41% | -9.9% |
Q2 2018 | $5,848,984 | -38.7% | 134,151 | -44.5% | 2.68% | -39.7% |
Q1 2018 | $9,546,676 | – | 241,688 | – | 4.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |